0001567619-22-020647.txt : 20221118 0001567619-22-020647.hdr.sgml : 20221118 20221118213229 ACCESSION NUMBER: 0001567619-22-020647 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221118 FILED AS OF DATE: 20221118 DATE AS OF CHANGE: 20221118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Walker Karin L CENTRAL INDEX KEY: 0001559422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35676 FILM NUMBER: 221403347 MAIL ADDRESS: STREET 1: C/O PROTHENA CORPORATION PLC STREET 2: 650 GATEWAY BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTHENA CORP PUBLIC LTD CO CENTRAL INDEX KEY: 0001559053 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 77 SIR JOHN ROGERSON'S QUAY, BLOCK C STREET 2: GRAND CANAL DOCKLANDS CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 BUSINESS PHONE: 011-353-1-236-2500 MAIL ADDRESS: STREET 1: 77 SIR JOHN ROGERSON'S QUAY, BLOCK C STREET 2: GRAND CANAL DOCKLANDS CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 FORMER COMPANY: FORMER CONFORMED NAME: Prothena Corp plc DATE OF NAME CHANGE: 20121102 FORMER COMPANY: FORMER CONFORMED NAME: Neotope Corp Ltd DATE OF NAME CHANGE: 20120926 4 1 doc1.xml FORM 4 X0306 4 2022-11-18 0 0001559053 PROTHENA CORP PUBLIC LTD CO PRTA 0001559422 Walker Karin L C/O PROTHENA BIOSCIENCES INC 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Accounting Officer Ordinary Shares, par value $0.01 per share 2022-11-18 4 M 0 10000 15.04 A 10000 D Ordinary Shares, par value $0.01 per share 2022-11-18 4 S 0 9774 57.0431 D 226 D Ordinary Shares, par value $0.01 per share 2022-11-18 4 S 0 226 58.2745 D 0 D Stock Option (right to buy) 15.04 2022-11-18 4 M 0 10000 0.00 D 2028-06-21 Ordinary Shares 10000 55481 D The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The transaction was executed in multiple trades in prices ranging from $56.39 to $57.34, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnotes 2 through 3 of this Form 4. The transaction was executed in multiple trades in prices ranging from $57.415 to $58.29, inclusive. The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on June 21, 2019, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. /s/ Michael Malecek, as Attorney in Fact for Karin L. Walker 2022-11-18